Skip to main content

Table 1 Baseline characteristics and anthropometric measurements of obese participants according to circulating PPARĪ³ level

From: Crosstalk between circulating peroxisome proliferator-activated receptor gamma, adipokines and metabolic syndrome in obese subjects

Characteristics

Low circulating PPARĪ³ (Meanā€‰Ā±ā€‰SEM) Ā¶ā€ 

High circulating PPARĪ³ (Meanā€‰Ā±ā€‰SEM) Ā¶ā€ 

95% confidence interval of the difference (Lower- Upper)

P valueā€ 

Age (year)

40.68ā€‰Ā±ā€‰1.65

37.44ā€‰Ā±ā€‰1.69

āˆ’1.47 to 7.95

0.176

Weight(kg)

88.54ā€‰Ā±ā€‰1.64

97.92ā€‰Ā±ā€‰2.56

āˆ’15.41 to-3.35

0.003*

BMI (kg/m2)

34.26ā€‰Ā±ā€‰0.56

36.42ā€‰Ā±ā€‰0.64

āˆ’3.86 to āˆ’0.46

0.013*

Fat (%)

40.73ā€‰Ā±ā€‰0.86

40.82ā€‰Ā±ā€‰0.98

āˆ’2.70 to 2.51

0.945

Fat mass (kg)

36.27ā€‰Ā±ā€‰1.14

39.72ā€‰Ā±ā€‰1.30

āˆ’6.88 to 0.003

0.050*

FFM (kg)

52.48ā€‰Ā±ā€‰1.13

58.21ā€‰Ā±ā€‰2.08

āˆ’10.43 to āˆ’1.01

0.018*

Visceral Fat (kg)

10.57ā€‰Ā±ā€‰0.53

11.48ā€‰Ā±ā€‰0.51

āˆ’2.38 to 0.55

0.221

Trunk Fat

18.09ā€‰Ā±ā€‰0.52

20.37ā€‰Ā±ā€‰0.65

āˆ’3.95 to āˆ’0.60

0.008*

FBS (mg/dl)

103.13ā€‰Ā±ā€‰3.73

113.11ā€‰Ā±ā€‰6.56

āˆ’24.90 to 4.93

0.191

TG (mg/dl)

130.90ā€‰Ā±ā€‰8.14

162.65ā€‰Ā±ā€‰11.18

āˆ’59.26 to āˆ’4.22

0.025*

Total Chol (mg/dl)

188.41ā€‰Ā±ā€‰4.97

195.91ā€‰Ā±ā€‰4.50

āˆ’20.84 to 5.85

0.267

HDL Chol (mg/dl)

49.93ā€‰Ā±ā€‰1.30

47.46ā€‰Ā±ā€‰1.45

āˆ’1.40 to 6.34

0.210

LDL Chol (mg/dl)

100.40ā€‰Ā±ā€‰3.39

103.93ā€‰Ā±ā€‰3.02

āˆ’12.57 to 5.50

0.439

AST (IU/L)

16.73ā€‰Ā±ā€‰1.03

19.56ā€‰Ā±ā€‰1.14

āˆ’5.89 to 0.22

0.069

ALT(IU/L)

14.42ā€‰Ā±ā€‰1.59

16.45ā€‰Ā±ā€‰1.76

āˆ’6.75 to 2.68

0.395

ALP(IU/L)

179.50ā€‰Ā±ā€‰6.67

185.22ā€‰Ā±ā€‰6.55

āˆ’24.32 to12.87

0.542

Hs-CRP (mg/l)

3.11ā€‰Ā±ā€‰0.41

3.68ā€‰Ā±ā€‰0.47

āˆ’1.81 to 0.67

0.368

Insulin (Ī¼lU/ml)

16.99ā€‰Ā±ā€‰1.03

18.36ā€‰Ā±ā€‰1.24

āˆ’4.57 to 1.85

0.402

HOMA-IR

4.43ā€‰Ā±ā€‰0.38

5.31ā€‰Ā±ā€‰3.52

āˆ’2.21 to 0.44

0.19

RMR (kcal/24Ā h)

1542.77ā€‰Ā±ā€‰56.79

1880.97ā€‰Ā±ā€‰84.04

āˆ’538.98 to-137.41

0.001*

BAI

39.22ā€‰Ā±ā€‰0.75

39.40ā€‰Ā±ā€‰0.86

āˆ’2.45 to 2.10

0.88

WC (cm)

97.87ā€‰Ā±ā€‰1.31

105.26ā€‰Ā±ā€‰1.60

āˆ’11.51 to āˆ’3.26

0.001*

SBP (mmhg)

124.95ā€‰Ā±ā€‰3.90

123.06ā€‰Ā±ā€‰2.98

āˆ’7.85 to11.62

0.702

DBP (mmhg)

86.65ā€‰Ā±ā€‰1.89

83.71ā€‰Ā±ā€‰2.07

āˆ’2.63 to 8.53

0.296

  1. *P-value ā‰¤0.05 are significant.
  2. ā€ Independent- Samples T Test.
  3. Ā¶Mean plus and minus Standard Error Mean.
  4. ā€ n of participants in low circulating PPARĪ³ group = 48, n of participants in high circulating PPARĪ³ group = 48.
  5. BMI, body mass index; FFM, free fat mass; FBS, fasting blood sugar; TG, triglyceride, LDL, low density lipoprotein; HDL, high density lipoprotein; AST, Aspartate transaminase; ALT, alanine aminotransferase; ALP, Alkaline phosphatase; hsCRP, High sensitivity c-reactive protein, HOMA-IR, Homeostasis Model of Assessment - Insulin Resistance; RMR, resting metabolic rate; BAI, Body Adiposity Index; WC, Waist Circumference, SBP, systolic blood pressure, DBP, diastolic blood pressure.